SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-17-009198
Filing Date
2017-10-06
Accepted
2017-10-06 14:00:51
Documents
3
Period of Report
2017-10-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT mbvx8k_oct62017.htm 8-K 37237
2 PRESS RELEASE ex99-1.htm EX-99.1 18361
3 IMAGE ex99-1000.jpg GRAPHIC 3804
  Complete submission text file 0001654954-17-009198.txt   62224
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37861 | Film No.: 171126614
SIC: 2834 Pharmaceutical Preparations